Q1 2026 · 13F-HR
Data Collective IV GP, LLCholdings as filed
Filed 2026-05-15 · accession 0001104659-26-062465
$55.9M
Reported value
4
Positions
2026-03-31
Period end
The Brief · Data Collective IV GP, LLC · Q1 2026
AI · grounded in 13F
Data Collective IV GP, LLC established a new position in Horizon Quantum Holdings Ltd valued at $8.04M. The fund also added a new stake in Definium Therapeutics, Inc. (MindMed) DFTX worth $1.9M. These additions coincided with the complete exit of its position in Mind Medicine (MindMed) Inc. BRD1EUR, which reduced the portfolio by $1.34M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 30049H102 | EVLV | Evolv Technologies Holdings, Inc. | $27.8M | 49.6% | 4,590,000 | Common | SOLE |
| 75629V104 | RXRX | Recursion Pharmaceuticals, Inc. | $18.2M | 32.6% | 5,941,120 | Common | SOLE |
| Y4000A102 | HQ | Horizon Quantum Holdings Ltd | $8.0M | 14.4% | 915,198 | Common | SOLE |
| 24477V105 | DFTX | Definium Therapeutics, Inc. (MindMed) | $1.9M | 3.39% | 100,350 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.